265 related articles for article (PubMed ID: 31835238)
1. Hippocampal [
Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
[TBL] [Abstract][Full Text] [Related]
2. Compensating for choroid plexus based off-target signal in the hippocampus using
Pawlik D; Leuzy A; Strandberg O; Smith R
Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062
[TBL] [Abstract][Full Text] [Related]
3. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
4. Regional [
Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
[TBL] [Abstract][Full Text] [Related]
5. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
6. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
7. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
Visser D; Wolters EE; Verfaillie SCJ; Coomans EM; Timmers T; Tuncel H; Reimand J; Boellaard R; Windhorst AD; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3165-3175. PubMed ID: 32462397
[TBL] [Abstract][Full Text] [Related]
8. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
9. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
10. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
12. A novel partial volume correction method for accurate quantification of [
Wolters EE; Golla SSV; Timmers T; Ossenkoppele R; van der Weijden CWJ; Scheltens P; Schwarte L; Schuit RC; Windhorst AD; Barkhof F; Yaqub M; Lammertsma AA; Boellaard R; van Berckel BNM
EJNMMI Res; 2018 Aug; 8(1):79. PubMed ID: 30112620
[TBL] [Abstract][Full Text] [Related]
13. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O
JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
15. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
16. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
Edwards L; La Joie R; Iaccarino L; Strom A; Baker SL; Casaletto KB; Cobigo Y; Grant H; Kim M; Kramer JH; Mellinger TJ; Pham J; Possin KL; Rosen HJ; Soleimani-Meigooni DN; Wolf A; Miller BL; Rabinovici GD
Neurobiol Aging; 2021 Sep; 105():86-98. PubMed ID: 34049062
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Tau PET Using
Visser D; Tuncel H; Ossenkoppele R; Yaqub M; Wolters EE; Timmers T; Weltings E; Coomans EM; den Hollander ME; van der Flier WM; van Berckel BNM; Golla SSV
J Nucl Med; 2023 Feb; 64(2):281-286. PubMed ID: 36265910
[TBL] [Abstract][Full Text] [Related]
18. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
[TBL] [Abstract][Full Text] [Related]
19. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
Parbo P; Ismail R; Sommerauer M; Stokholm MG; Hansen AK; Hansen KV; Amidi A; Schaldemose JL; Gottrup H; Brændgaard H; Eskildsen SF; Borghammer P; Hinz R; Aanerud J; Brooks DJ
Neurobiol Dis; 2018 Sep; 117():211-216. PubMed ID: 29902557
[TBL] [Abstract][Full Text] [Related]
20. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.
Wolters EE; van de Beek M; Ossenkoppele R; Golla SSV; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Barkhof F; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lemstra AW; van Berckel BNM
Neuroimage Clin; 2020; 28():102504. PubMed ID: 33395993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]